← Back to Search

Cognitive Behavioral Therapy

Empower@Home for Depression

N/A
Waitlist Available
Led By Xiaoling Xiang, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 10 weeks
Awards & highlights

Study Summary

This trial tests a new online therapy for older adults with depression. Over 35 people in Michigan will use it over 10 weeks, with fewer symptoms afterwards. Minimal support is needed.

Who is the study for?
This trial is for individuals aged 60 or older living in Michigan who are experiencing at least mild depressive symptoms but do not have severe vision impairment, cognitive impairments, substance use disorders, active suicidal thoughts, terminal illnesses with high hospitalization risk, or those currently receiving psychotherapy.Check my eligibility
What is being tested?
The study tests an internet-based cognitive behavioral therapy program called Empower@Home. It's designed to help reduce depression in older adults over ten weeks. Participants will be randomly assigned to either start the program right away or placed on a waitlist as a control group.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on cognitive behavioral therapy delivered online, there may be minimal side effects such as discomfort from confronting personal issues or temporary increases in distress as participants work through the therapeutic material.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Patient Health Questionnaire-9 (PHQ-9)
Modified Treatment Evaluation Inventory
Secondary outcome measures
Change in EQ5D-5L
Change in Generalized Anxiety Disorder Assessment-7 (GAD-7)
Change in Patient-Reported Outcomes Measurement Information Systems (PROMIS)-Global Health
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Internet-based programExperimental Treatment1 Intervention
Group II: WaitlistActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Empower@Home
2022
N/A
~10

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,883 Total Patients Enrolled
67 Trials studying Depression
69,053 Patients Enrolled for Depression
Xiaoling Xiang, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
240 Total Patients Enrolled
1 Trials studying Depression
240 Patients Enrolled for Depression

Media Library

Empower@Home (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05593276 — N/A
Depression Research Study Groups: Waitlist, Internet-based program
Depression Clinical Trial 2023: Empower@Home Highlights & Side Effects. Trial Name: NCT05593276 — N/A
Empower@Home (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05593276 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project still seeking volunteers?

"According to the data on clinicaltrials.gov, this research is no longer enlisting patients; it was initially posted on May 1st 2023 and underwent its latest update in November of 2022. However, there are currently 2339 different studies actively recruiting candidates at present."

Answered by AI

What is the ultimate aim of this clinical investigation?

"The primary assessment of this 10-week trial will be the Change in Patient Health Questionnaire-9 (PHQ-9). Supplementary metrics which will also be measured include a Change in EQ5D-5L, a metric that gauges health related quality of life; Change in PROMIS Global Health, a standardized 9 item measure for global well being; and finally, Changes to PROMIS Social Isolation – an 8 item indicator for loneliness. All scores range from low to high values with higher numbers indicating better patient outcomes."

Answered by AI

Who else is applying?

What state do they live in?
Nebraska
Texas
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
The Preliminary Effects of Empower@Home
Xiaoling Xiang 2023. "The Preliminary Effects of Empower@Home". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05593276.
~4 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top